FN2 Earnings Intelligence
Colgate-Palmolive (CL) earnings history
Colgate-Palmolive Company (CL) quarterly earnings scorecards, market reactions, transcript intelligence, and historical context.
Earnings History
Colgate-Palmolive Company
The quarter supports a mixed but constructive view: resilient demand, emerging-market momentum, premium innovation, and margin execution are positives, while the U.S. recovery and cost volatility remain key tests.
Colgate-Palmolive Company
Colgate-Palmolive beat Q1 2026 estimates with EPS of $0.97 (vs. $0.943 est.) and revenue of $5.32B (vs. $5.22B est.), powered by volume-led organic sales growth in emerging markets, particularly Asia Pacific. Despite lowering gross margin guidance on $300M of assumed raw material and packaging cost inflation (oil at $110/barrel), management maintained overall sales and EPS guidance, pointing to an expanded SGPP savings program ($350-500M, potentially $550M) expected to yield $200-300M in annualized savings beginning largely in 2027-28. North America remained soft but is targeted with brand interventions and new product launches. Hill's pet care posted double-digit premium growth. The stock rose 2.23% on 1.70x baseline volume, with a subsequent drift of +1.34%. Analyst consensus target stands at $96.30 versus a current price of $92.73.
Colgate-Palmolive Company
The call supports a constructive but conditional view: resilient demand, emerging-market momentum, premium innovation, and operational investment provide support, while category growth, consumer uncertainty, foreign exchange, and promotion remain important tests.
Colgate-Palmolive Company
The supplied analysis supports a cautiously constructive operating thesis: brand strength, innovation, pricing tools, and supply-chain flexibility may support resilience, but tariff costs, consumer softness, private-label exit, and commodity inflation remain material offsets.
Colgate-Palmolive Company
The supplied analysis supports a constructive but conditional view: resilient demand, innovation, Hill’s pet nutrition, and margin expansion underpin growth, while FX, tariffs, pricing pressure, and volume risks remain material.
Get the CL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.